95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Organic electroluminescent materials and devices
#3602Compound amycolamicin, method for producing the same, and use of the same
#3603Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3604Bi-heteroaryl compounds as Vps34 inhibitors
#3605Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#3606ANTI-VIRAL COMPOUNDS
#3607Pyridazinone derivatives
#3608Azetidine and piperidine compounds useful as PDE10 inhibitors
#3609Spiro compounds as Hepatitis C virus inhibitors
#3610Organic electroluminescent materials and devices
#3611Azolium and purinium salt anticancer and antimicrobial agents
#3612Pyrazole compounds for controlling invertebrate pests
#3613Substituted benzoazepines as toll-like receptor modulators
#3614Compounds for the treatment of HIV
#3615Nitrogen-containing aromatic heterocyclic compound
#3616Substituted sulfonamides useful as antiapoptotic Bcl inhibitors
#3617Microbiocidal heterocycles
#3618Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#3619Pyrimidinyl pyridazinone derivatives
#3620Piperazine compound capable of inhibiting prostaglandin D synthase
#3621METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
#3622Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
#3623Cyclic amide BACE-1 inhibitors having a benzamide substituent
#3624Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#3625Heterocyclic compound and organic light-emitting device including the same
#3626Compounds for organic electronic material and organic electroluminescent device using the same
#36274-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#3628COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#3629Compound and organic light emitting device including the same
#3630NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
#3631Benzimidazole-imidazole derivatives
#3632Non-nucleoside reverse transcriptase inhibitors
#3633Methods of Using PI3K and MEK Modulators
#3634Substituted isoquinolinones and methods of treatment thereof
#3635Triazolones as fatty acid synthase inhibitors
#3636Lubricants for data storage
#3637Modified carbocyanine dyes and their conjugates
#3638Androgen receptor modulating carboxamides
#3639Pyrazole derivative
#3640Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#3641Substituted indazole derivatives active as kinase inhibitors
#3642Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
#3643VEGFR3 inhibitors
#3644Fast drying aqueous amine free coating composition(s)
#3645High transmissional yellow dye for LCD and synthetic method thereof
#3646VEGFR3 inhibitors
#3647SMAC mimetic for treating myelodysplastic syndromes
#3648Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
#3649Modulators of cellular adhesion
#3650Inhibitors
#3651Organic light-emitting diode and method for manufacturing same
#3652SOLID STATE FORMS OF A POTENT HCV INHIBITOR
#3653Inhibitors of beta-secretase
#3654Bisubstrate fluorescent probes for protein kinase CK2
#3655Pyrazolyl-pyrimidine derivatives as kinase inhibitors
#3656Modulators of cellular adhesion
#36571,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#3658Antiviral compounds
#3659Hepatitis C virus inhibitors
#3660Compound for organic optoelectronic device and organic light emitting diode including the same
#3661Biscarbazole derivative and organic electroluminescent element using same
#3662Pesticidal arylpyrrolidines
#3663Acid addition salts of risperidone and pharmaceutical compositions thereof
#3664Pyrimidine derivatives
#3665Kinase inhibitors and method of treating cancer
#3666Kinase inhibitors and method of treating cancer with same
#3667Labeled, non-peptidic, multivalent integrin antagonist compounds; methods for synthesis and uses thereof
#3668Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
#3669Antiviral compounds
#3670Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine Hreceptor
#3671Imidazole based LXR modulators
#3672Substituted amino-pyrimidine derivatives
#3673Substituted dihydropyrazolones and their use
#3674AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS
#3675Luminescence quenching compounds
#3676Inhibitors of protein kinases
#3677Bicyclic compounds as Pim inhibitors
#36782,4-pyrimidinediamine compounds and their uses
#3679Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#3680Insecticidal arylpyrrolines
#3681Pyridazinone compounds
#3682N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
#3683No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents
#3684Unsymmetrical bisazides for chemoselective sequential ligation
#3685Hepatitis C Virus Inhibitors
#3686Antiviral compounds
#3687Hepatitis C virus inhibitors
#3688Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#3689Heteroaryl quinazoline derivatives
#3690Benzoimidazoles as prolyl hydroxylase inhibitors
#3691SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS
#3692Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
#3693Aryl-substituted imidazoles
#36941,2,4-triazine-6-carboxamide kinase inhibitors
#3695AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER
#3696Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
#3697Compounds for the treatment of proliferative disorders
#3698Ring-substituted N-pyridinyl amides as kinase inhibitors
#3699Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
#3700Synthesis of antiviral compound
#3701AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS
#3702FAK INHIBITORS
#37032,4-pyrimidinediamine compounds and their uses
#3704Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
#3705Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
#3706Solid forms of an antiviral compound
#3707Hepatitis C virus inhibitors
#3708Organic electroluminescent element
#3709Modulators of TNF-α signaling
#3710Substituted sodium-1H-pyrazole-5-olate
#3711Modulators of calcium release-activated calcium channel
#3712N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators
#3713Cyclohexyl-azetidinyl antagonists of CCR2
#3714Compounds and compositions as kinase inhibitors
#3715Pyrimidine compounds as delta opioid receptor modulators
#3716Antiviral compounds
#3717Compounds for the treatment of -associated disease
#3718Aromatic heterocycle derivative and organic electroluminescent element using same
#3719Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
#3720PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS
#3721HCV Protease Inhibitors and Uses Thereof
#3722Pyridine compounds and the users thereof
#3723Quinoxalines and AZA-quinoxalines as CRTHreceptor modulators
#3724Triazine compounds
#3725NAMPT inhibitors
#3726Triazole compounds that modulate HSP90 activity
#3727Protein kinase inhibitors
#3728Complement pathway modulators and uses thereof
#3729Hedgehog pathway modulators
#3730Bicyclic compound or salt thereof
#3731INHIBITORS OF HCV NS5A
#3732Tricyclic fused ring inhibitors of hepatitis C
#3733Linked dibenzimidazole antivirals
#3734Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
#3735Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the organic light emitting diode
#3736Indole or indazole derivative or salt thereof
#3737Dimeric IAP inhibitors
#3738Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
#3739Cyclopropanecarboxylate esters of purine analogues
#3740Indolin-2-one derivatives as protein kinase inhibitors
#3741Pyridinones/pyrazinones, method of making, and method of use thereof
#3742Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
#3743Small molecule apoptosis promoters
#3744Hepatitis C virus inhibitors
#3745Chemical compounds
#3746Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
#3747Substituted pyrimidine compounds and their use as SYK inhibitors
#3748Indazolyl triazol derivatives
#3749Compound for organic light-emitting diode and organic light-emitting diode including the same
#3750Substituted quinoxalines as FGFR kinase inhibitors
#3751Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them
#3752Organic electroluminescent device
#3753Material for organic electroluminescence device and organic electroluminescence device
#3754Pyridazinyl derivatives as SMO inhibitors
#3755MESYLATE SALT FORMS OF A POTENT HCV INHIBITOR
#3756Indazole derivatives useful as ERK inhibitors
#3757Pyridazinones, method of making, and method of use thereof
#3758Benzimidazole compound, organic photoelectric device including the same, and display element including the same
#3759Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
#3760Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof
#3761Dual-acting pyrazole antihypertensive agents
#3762Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use
#3763Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
#3764Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
#3765Materials for organic electroluminescent devices
#3766Material for organic electroluminescence device and organic electroluminescence device
#3767Halogenated compounds for photodynamic therapy
#3768Substituted pyrimidinyl-amines as protein kinase inhibitors
#3769Amino pyrimidine anticancer compounds
#3770Benzocyanine compounds
#3771Serine/threonine kinase inhibitors
#37722-CYCLOQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF
#3773Pyrrolidine derived β3 adrenergic receptor agonists
#3774SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS
#37757-CYCLYLQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF
#3776Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
#3777Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
#3778Cyclic amine azaheterocyclic carboxamides
#3779INDOLE DERIVATIVES
#3780Compounds for modulating RNA binding proteins and uses therefor
#3781Compositions and methods for treatment of neurodegenerative disease
#3782Carbazole compound, material for organic electroluminescence device and organic electroluminescence device
#3783ANTIMICROBIAL COMPOSITION
#3784Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia
#3785Heterocyclic compounds and uses thereof
#3786Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same
#3787Quinazolinone-type compounds as CRTH antagonists
#3788Pyridine-2-derivatives as smoothened receptor modulators
#3789Potent and selective inhibitors of hepatitis C virus
#3790Inhibitors of HCV NS5A
#3791Triphenylene-based materials for organic electroluminescent devices
#3792Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
#3793FATTY ACID SYNTHASE INHIBITORS
#3794Heterocyclic compounds as inhibitors of leukotriene production
#3795Alkoxy-substituted 2-aminopyridines as ALK inhibitors
#3796Magnetic media and magnetic recording devices using fluorine compounds
#3797Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
#3798Pyridazinone derivatives
#3799Modulators of amyloid beta
#3800COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
#3801Quinazoline derivatives substituted by aniline, preparation method and use thereof
#3802Pyridazinone derivatives
#3803Pyridazinone derivatives
#3804Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
#3805Substituted triazoles useful as mGlu5 receptor modulators
#3806Hepatitis C virus inhibitors
#3807Substituted bicyclic HCV inhibitors
#3808COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
#3809Phenylquinazoline derivatives
#38102,4,5-trisubstituted imidazoles and their use as anti-microbial agents
#3811Condensed-cyclic compound and organic light emitting diode including the same
#3812METHOD OF MAKING BENZAZOLES
#3813Chemokine receptor modulators
#3814Azetidine derivatives
#3815Fused bicyclic mTOR inhibitors
#3816BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE
#3817Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#3818Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
#3819Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
#3820Tyrosine Kinase Inhibitors
#3821Compounds
#3822Pyrimidine derivatives as FAK inhibitors
#3823Azetidine derivatives
#3824Benzimidazole analogues for the treatment or prevention of flavivirus infections
#3825FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS
#3826Electron transport material and organic light emitting device
#3827Hypoglycemic compounds
#3828Heterocyclic compound
#3829Compounds
#38302,4-pyrimidinediamine compounds and their uses
#3831Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
#3832Heterocyclic compound
#3833Compounds
#3834Bicyclic aryl and heteroaryl sodium channel inhibitors
#3835Substituted pyrimidinone-phenyl-pyrimidinyl compounds
#3836Piperazine derivatives and methods of use
#3837N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof
#3838MODULATORS FOR AMYLOID BETA
#38394-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors
#3840Bicarbazole compounds for OLEDs
#3841Antiviral compounds
#3842Fused heterocyclic ring compound
#3843N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
#3844Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
#3845Azetidinyl diamides as monoacylglycerol lipase inhibitors
#3846Inhibitors of JAK
#3847Pyridine derivatives useful as kinase inhibitors
#3848Tricarbonyl complexes with tridentate chelators for myocardium imaging
#3849PYRIDONE GLUCOKINASE ACTIVATORS
#3850PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS
#3851Pharmacokinetically improved compounds
#3852Substituted pyrazine-2-carboxamide kinase inhibitors
#3853Targeted delivery using tissue-specific peptidomimetic ligands
#3854Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
#3855Tricarbonyl complexes with tridentate chelators for myocardium imaging
#3856Compound having indenocarbazole ring structure, and organic electroluminescent device
#3857Heterocyclic compounds useful for kinase inhibition
#3858Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules
#3859Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
#3860Hetero-bicyclic derivatives as HCV inhibitors
#3861Azetidinyl diamides as monoacylglycerol lipase inhibitors
#3862Hepatitis C virus inhibitors
#3863LIPOIC ACID AND NITROXIDE DERIVATIVES AND USES THEREOF
#3864Substituted pyridazines for controlling invertebrate pests
#3865INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#3866TYROSINE KINASE INHIBITORS
#3867Hepatitis C Virus Inhibitors
#3868Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
#3869Radioprotector compounds and methods
#3870Method for Synthesizing 1,3,5-Tri-(N-Phenylbenzimidazolyl) Benzene
#3871ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#3872Azetidinyl diamides as monoacylglycerol lipase inhibitors
#3873Material for organic photoelectric device, and organic photoelectric device including the same
#3874Materials for organic electroluminescent devices
#3875Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
#3876Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
#3877Pyrazole compounds useful as protein kinase inhibitors
#3878Aminopyrimidine derivatives as LRRK2 modulators
#3879Inhibitors of HCV NS5A
#3880Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
#3881Analogues for the treatment or prevention of flavivirus infections
#3882Synthetic mimetics of host defense and uses thereof
#3883BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES
#3884N-heteroaryl substituted triazoles and N-heteroaryl substituted triazoles useful as axl inhibitors
#3885Pyrimidine derivatives
#3886Amido compounds as RORγt modulators and uses thereof
#3887ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#3888Hepatitis C virus inhibitors
#3889Pyrazole compound and pharmaceutical use thereof
#3890Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
#38911,3,6-substituted indole derivatives having inhibitory activity for protein kinase
#3892Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
#3893Carbazole Compound, Light-Emitting Element Material, and Organic Semiconductor Material
#3894ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#3895Formulations containing pyridazine compounds
#3896Triazole compounds that modulate Hsp90 activity
#3897Pyrazolyl quinoxaline kinase inhibitors
#3898Polyurethane derivatives, composition thereof and dye additives comprising the polyurethane derivatives
#3899Processes for preparing substituted pyrimidines
#3900Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof